SEARCH · Search PubMed

Results for “CHROMIUM”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

SourceResearch connectionFrom yearThrough year

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 631 records · Page 35Linked to original sources

PubMed2006

A mass balance approach for evaluating leachable arsenic and chromium from an in-service CCA-treated wood structure.

Many existing residential wood structures, such as playsets and decks, have been treated with chromated copper arsenate (CCA). This preservative chemical can be released from these structures incrementally over time through contact with rainfall. The objective of this study was to evaluate the levels of arsenic and chromium leached from an in-service CCA-treated deck exposed to rainfall, as well as their possible impacts on soils and shallow groundwater. Two monitoring stations, one containing a CCA-treated deck and the other containing an untreated deck as a control, were constructed outside for this study. Rainfall, runoff water from the decks, soils below the decks, and infiltrated water through 0.7-m depth of soil were monitored for arsenic and chromium over a period of 3 years. The concentration of the CCA-treated deck runoff for arsenic (0.114-4.66 mg/L) and chromium (0.008-0.470 mg/L) were significantly (p<0.001) higher than the untreated deck runoff (< or =0.002 mg/L for both). During the 3-year monitoring period, 13% of the arsenic and 1.4% of the chromium were leached from the amount initially present in the CCA-treated wood. Arsenic levels (<0.1-46 mg/kg) in soils under the CCA-treated deck were significantly (p<0.001) higher than under the untreated deck (<0.1-2.7 mg/kg), while chromium levels were statistically the same below the two decks (2.4-9.6 mg/kg). Approximately 94% of the arsenic from the runoff was absorbed in the soils below the CCA-treated deck; the upper 2.5 cm of the soils captured 42% of the total. The infiltrated water concentrations for arsenic (<0.001-0.085 mg/L) and chromium (<0.001-0.010 mg/L) below the CCA-treated deck were both significantly (p<0.001) higher than below the untreated deck (< or =0.006 mg/L). The amounts of arsenic found in the infiltrated water below the CCA-treated deck represented 6% of total arsenic leached and less than 0.7% of the initial mass in the wood. The study demonstrated that exposure of a CCA-treated deck to rainfall resulted in elevated arsenic concentrations in both runoff and soil. Although only a relatively small fraction of the initial arsenic from the wood was found to infiltrate through the soil, these impacts were significant and caused the infiltrated water to exceed drinking water standards. The study suggests that potential exposures to arsenic exist indirectly through an environment that is contaminated with arsenic leached from in-service CCA-treated wood.

Architecture↗

PubMed1999

Chromium(VI)-mediated DNA damage: oxidative pathways resulting in the formation of DNA breaks and abasic sites.

Inside cells chromium(VI) is activated to its ultimate carcinogenic form by reducing agents including glutathione (GSH) and ascorbate (AsA). The precise mechanism by which DNA damaging species are formed is unclear. In earlier in vitro work with isolated DNA we have shown that chromium(VI) in combination with GSH or AsA is able to induce similar numbers of single strand breaks and apurinic/apyrimidinic sites (AP-sites). Moreover, the formation of both lesions followed a similar temporal pattern. It is conceivable that the two forms of DNA damage arise from a common precursor lesion (e.g. hydrogen abstraction at C4' of the DNA sugar moiety) with a partitioning along two pathways, one yielding an AP-site, the other a single strand break (SSB) and a base propenal. The present study is intended to test this hypothesis by analysing whether oxidation products of deoxyribose can be formed in the presence of chromium(VI) and GSH or AsA. It was found that mixtures of chromium(VI) and GSH or AsA were able to oxidise 2-deoxyribose to yield malondialdehyde, which was detected by reaction with thiobarbituric acid. The characteristic pink chromogen, which forms upon reaction with thiobarbituric acid, was also observed with calf thymus DNA as the substrate. In both experimental systems the addition of catalase prevented the formation of deoxyribose breakdown products. Hydroxyl radicals did not seem to be important for the generation of DNA damage as the characteristic modified DNA bases could not be detected by using gas chromatography-mass spectrometry. These results lead us to conclude that the formation of SSB during the reductive conversion of chromium(VI) proceeds primarily via hydrogen abstraction from C4'. The observation that Fenton chemistry is not involved in these processes is intriguing and necessitates further research into the ways in which chromium can activate molecular oxygen to form DNA damaging species.

Animals↗

PubMed1992

Residential exposure to chromium waste--urine biological monitoring in conjunction with environmental exposure monitoring.

To determine whether a population living on or adjacent to four sites of chromate production waste was measurably exposed to environmental chromium, spot samples of urine were collected along with wipe samples of household dust and lifestyle/activity interview data. Findings were compared to those from a control population in two communities with no significant chromium use or waste sites. Urine samples were collected and analyzed, employing measures to minimize background chromium contamination. The average Cr mass in dust was 3.7 times that in control houses. The mean creatinine-corrected urine Cr (Cr/c) level of the exposed subgroup residing in households in the 75th percentile of Cr mass in wipe samples was significantly greater than that of the control population. This subgroup was primarily located at a single exposure location. Using lifestyle/activity data, significantly elevated Cr/c urine levels were identified in other exposed subgroups defined by employment location and by outside play time. These data show an association between elevated exposure to chromium in household dust and elevated urine levels of chromium, consistent with residential exposure to chromate production waste. These data also suggest an association between chromium exposure and activities outside the home which are consistent with exposure to chromate production waste.

Adolescent↗

PubMed1997

Occupational exposure to chromium and nickel in the 1980s in Finland.

Two large data bases accumulated from the 1980s at the Finnish Institute of Occupational Health, one with results on urinary chromium and nickel analyses and the other with results on total and hexavalent chromium and nickel, were compiled and analysed in order to clarify the occupational exposure during the 1980s, and to reveal possible trends in the exposure of workers in different jobs. The data were processed in three batches: years 1980-1982, 1983-1985 and 1986-1989. The median values of urinary chromium exceeded the biomonitoring action level, BAL, in metal workers, and the mean values exceeded the BAL in both metal workers and plasma cutters. Among all worker groups the median values of urinary chromium remained quite stable during the study period. The median values of urinary nickel concentration did not exceed the BAL in any worker group studied, but an increasing trend was observed among moulders. In the breathing zone of grinders, the median value of total or trivalent chromium exceeded the occupational exposure limit, OEL. The medial of hexavalent chromium concentration in the breathing zone of metal sprayers and spray painters was higher than the OEL. No decreasing trend in exposure could be observed during the 10-year period in breathing zone air.

Air Pollutants, Occupational↗

PubMed2003

Comparison of the cytotoxicity of clinically relevant cobalt-chromium and alumina ceramic wear particles in vitro.

Concern over polyethylene wear particle induced aseptic loosening of metal-on-polyethylene hip prostheses has led to renewed interest in alternative materials such as metal-on-metal and alumina ceramic-on-alumina ceramic for total hip replacement. This study compared the effects of clinically relevant cobalt-chromium and alumina ceramic wear particles on the viability of U937 histiocytes and L929 fibroblasts in vitro. Clinically relevant cobalt-chromium wear particles were generated using a flat pin-on-plate tribometer. The mean size of the clinically relevant metal particles was 29.5+/-6.3 nm (range 5-200 nm). Clinically relevant alumina ceramic particles were generated in the Leeds MkII anatomical hip simulator from a Mittelmieier prosthesis using micro-separation motion. This produced particles with a bimodal size distribution. The majority (98%) of the clinically relevant alumina ceramic wear debris was 5-20 nm in size. The cytotoxicity of the clinically relevant wear particles was compared to commercially available cobalt-chromium (9.87 microm+/-5.67) and alumina ceramic (0.503+/-0.19 microm) particles. The effects of the particles on the cells over a 5 day period at different particle volume (microm(3)) to cell number ratios were tested and viability determined using ATP-Lite(TM). Clinically relevant cobalt-chromium particles 50 and 5 microm(3) per cell reduced the viability of U937 cells by 97% and 42% and reduced the viability of L929 cells by 95% and 73%, respectively. At 50 microm(3) per cell, the clinically relevant ceramic particles reduced U937 cell viability by 18%. None of the other concentrations of the clinically relevant particles were toxic. The commercial cobalt-chromium and alumina particles did not affect the viability of either the U937 histiocytes or the L929 fibroblasts.Thus at equivalent particle volumes the clinically relevant cobalt-chromium particles were more toxic then the alumina ceramic particles. This study has emphasised the fact that the nature, size and volume of particles are important in assessing biological effects of wear debris on cells in vitro.

Aluminum↗

PubMed1990

Increased content of chromium and nickel in lung tissues from patients with bronchial carcinoma.

Epidemiological studies have shown that occupational exposure to certain chromium and nickel compounds is followed by an increased lung cancer incidence. However, few data exist on the content of these metals in lung cancer patients in general. In the present study, central and peripheral lung tissue, bronchial tissue and hilar lymph nodes were collected from 20 patients with bronchial carcinoma and 21 control individuals, and the tissue concentration of chromium and nickel was measured by use of atomic absorption analysis. Increased levels of both metals were found in cancer patients as compared to controls. Lung tissue concentration of chromium was two-fold increased, while the bronchial wall content of nickel was three times the level in control individuals. Smokers showed a dose-related increase in the deposition of both chromium and nickel. Furthermore, in cancer patients an inverse relationship between smoking and the tissue level of chromium in regional lymph nodes was found, possibly indicating a depressive effect on pulmonary clearance mechanisms. Our results emphasize the possible role of small amounts of chromium and nickel as agents in bronchial carcinogenesis, unrelated to occupation and probably related to tobacco smoking.

Adult↗

PubMed1996

Chromium induced teratogenicity in female rat.

Exposure to chromium (VI) (250, 500 and 750 ppm as potassium dichromate) via drinking water pregestationally in rats revealed embryo- and fetotoxic effects in the form of a significant reduction in the number of implantations and number of fetuses. An increase in the number of resorptions, pre-implantation and post-implantation loss in chromium (VI)-treated mothers was also observed. No significant visceral abnormality was found. A significant increase in sub-dermal hemorrhagic patches on thoracic and abdominal areas was found. Skeletal abnormality in the form of reduced ossification in parietal, interparietal and caudal bones was found in the fetuses of chromium (VI)-treated mothers. Chromium levels in blood, placenta and fetuses were found to be significantly increased in the 500 ppm and 750 ppm dosed groups. The duration of estrus cycle was significantly altered after chromium (VI) exposure. This study suggests that chromium exposure in rat causes a lower degree of toxicity than in mice as observed in our earlier studies.

Abnormalities, Drug-Induced↗

PubMed2002

Chromium speciation in rainwater: temporal variability and atmospheric deposition.

The concentrations of the various chromium species were determined in 89 rainwater samples collected in Wilmington, NC, from October 1, 1999, to December 31, 2001. Volume-weighted annual average concentrations of Cr(total), particulate Cr, Cr(III)(aq), and Cr(VI)(aq) were 4.6, 2.2, 0.8, and 1.2 nM, respectively. There was distinct seasonal and diurnal variability in the concentrations of the various chromium species. Chromium emissions to the global atmosphere by both natural and anthropogenic sources are estimated to be 2.2 x 10(9) mol/yr. Using our rainwater concentration data along with other published rainwater Cr concentrations and an estimate for total global annual rain, the total global flux of chromium removed from the atmosphere via wet deposition is 2.1 x 10(9) mol/yr. This represents complete removal of Cr and indicates that essentially all chromium released into the global atmosphere is removed via rain. About half this chromium is dissolved with roughly equal concentrations of toxic Cr(VI) and relatively harmless Cr(III) species.

Air Pollutants↗

PubMed2000

Enhanced organically bound chromium yeast production.

This paper describes continuous and fed-batch fermentation protocols for enhanced production of organically bound chromium yeast. During continuous fermentation, several inorganic chromium compounds were evaluated. Sodium chromate demonstrated the best chromium incorporation into yeast biomass without any precipitation in the fermentation medium. During fed-batch fermentation, several sodium chromate concentrations were evaluated at 1.1, 3.5, 5.9, 7.1, 8.3, and 10.8 g/L with continuous or single-dose addition. For single-dose addition of sodium chromate, some precipitation was observed for all concentrations, which reduced the available chromium in the fermentation medium. Adapted strain C11-1, obtained during continuous fermentation, produced higher biomass than the wild type but significantly lowered chromium incorporation. Pilot-scale fermentation demonstrated similar total chromium incorporation (2966 ppm) with lower biomass production compared to benchtop fermentation performed at the same sodium chromate addition.

Chromium↗

PubMed2001

Speciation and recovery of chromium from chromite ore processing residues.

The processing of chromite ore is associated with the generation of large quantities of solid wastes containing chromium, which have been disposed of as landfill for many years. The mobilization and operational speciation of chromium contained in soils contaminated with metal salts are important in terms of the environment. Several methods have been employed for the extraction and recovery of solid wastes. Chromium contained in contaminated soils and solid wastes can be categorized as exchangeable, oxidizable, carbonate-bound, reducible and residual. The results from this study indicate a need for efficient leaching methodologies in chromite ore processing plants to decrease the non-detrital fractions of chromium in the residue. Aggressive methodologies are required to recover chromium from the detrital fractions. The potential benefits of employing sodium peroxide for the complete recovery of chromium from chromite residue have been demonstrated, and the need to ensure the safety of the process has been emphasized.

Chromium↗

PubMed1999

Differentiation of normal human keratinocytes influences hexavalent chromium uptake and distribution and the ability of cells to withstand Cr(VI) cytotoxicity.

The degree of differentiation of normal human keratinocytes determines the biology of the cells to a large extent. We have previously documented that keratinocytes from different donors differ significantly in their ability to withstand hexavalent chromium [Cr(VI)]-induced cytotoxicity. Several factors may contribute to this differing donor sensitivity to Cr(VI). The aims of this study were to investigate to what extent keratinocyte differentiation might influence Cr(VI) uptake and the ability of cells to withstand Cr(VI)-induced cytotoxicity. Keratinocytes from different donors were cultured under identical conditions and exposed to Cr(VI) (as potassium dichromate) at different points during their maturation process. The degree of differentiation of the cells was assessed using a quantitative assay for involucrin and related to the Cr(VI) cytotoxicity experienced by the cells. Chromium content was measured in whole cell, cytosolic and particulate fractions. While proliferative keratinocytes exposed to Cr(VI) showed a high degree of cytotoxicity to dichromate exposure, the more differentiated cells showed significantly less cytotoxicity but a higher uptake of the metal ion into the cells. The relative percentage of cytosolic chromium was high in the proliferative cells and decreased as the cells matured, suggesting that differentiated cultures were binding most of the chromium to the particulate fraction. Total chromium also increased during differentiation. The use of the channel-blocking agent 4, 4'-diisothiocyanate-2-2'-stilbenedisulphonic acid confirmed the spatial differences of chromium accumulation in the phenotypically different cultures, in that it prevented Cr(VI) entry into the proliferative cells and attenuated dichromate cytotoxicity in these cultures, but had no effect on the Cr(VI) uptake in differentiated cells, nor did it reduce its cytotoxicity. These data support the hypothesis that the upper differentiated layers of the epidermis are able to offer considerable physical protection to the lower proliferative layers from chemical pro-oxidants.

4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid↗

PubMed2000

Isolation and characterization of a chromium-reducing bacterium from a chromated copper arsenate-contaminated site.

A Gram-negative bacterium (CRB5) was isolated from a chromium-contaminated site that was capable of reducing hexavalent chromium to an insoluble precipitate, thereby removing this toxic chromium species from solution. Analysis of the 16S rRNA from the isolate revealed that it was a pseudomonad with high similarity to Pseudomaonas synxantha. CRB5 was tolerant to high concentrations of chromate (500 mg l(-1)) and can reduce Cr(VI) under aerobic and anaerobic conditions. It also exhibited a broad range of reduction efficiencies under minimal nutrient conditions at temperatures between 4 degrees C and 37 degrees C and at pH levels from 4 to 9. As reduction increased, so did total cellular protein, indicating that cell growth was a requirement for reduction. Under low nutrient conditions with CRB5 or when using non-sterile contaminated groundwater from the site, reduction of Cr(VI) was followed by a increase in solution turbidity as a result of the formation of fine-grained Cr(III) precipitates, most probably chromium hydroxide mineral phases such as Cr(OH)3. Chromium adsorption and precipitation, as observed by transmission electron microscopy coupled with energy dispersive X-ray spectroscopy (TEM/EDS), revealed that the surfaces of the cells were uniformly stained with bound Cr(III) and amorphous precipitates (as determined by selected area electron diffraction; SAED). A mass balance of chromium in a batch bioreactor revealed that up to 30% of the total Cr was as settable precipitates or bound to cells.

Arsenates↗

PubMed2003

In vivo antioxidant properties of vitamin E and chromium in cold-stressed Japanese quails.

An experiment was conducted to determine if vitamin E (alpha-tocopherol-acetate) and chromium (chromium picolinate, Cr Pic) supplementation attenuate the negative effects of cold stress on egg production, egg quality, serum metabolites, and antioxidant status in Japanese quails (Corurnix coturnix japonica). One hundred and fifty laying Japanese quails (50-day-old) were divided into five groups, 30 birds per group. The laying quails kept at 6 degrees C for 12 h/d (08.00 p.m. to 08.00 a.m.) were fed either a basal diet (low temperature-basal diet, CS group) or the basal diet supplemented with either 400 microg of Cr/kg of diet (Cr group), 250 mg of alpha-tocopherol-acetate per kg of diet (Vit. E group) or 400 microg of Cr plus 250 mg of alpha-tocopherol-acetate per kg of diet (Vit. E + Cr group) while quails kept at 18 degrees C were fed a basal diet (thermo-neutral-basal diet, TN group). Performance and egg quality were significantly reduced in CS group compared with TN group. Supplemental chromium and vitamin E significantly increased live weight change, egg production, and improved feed efficiency in cold-stressed laying hens compared with the group fed the basal diet at 6 degrees C. Egg production and egg weight were also greater (P < 0.05) in each supplemental group compared with the CS group. However, a combination of vitamin E and chromium, rather than each separately, provided the greatest performance. Supplemental vitamin E and chromium also increased serum vitamin C and E but, decreased malondialdehyde (MDA) concentrations (P < 0.05); the combination of vitamin E and chromium resulted in the highest levels of serum vitamin C and E within the cold-stressed quails. Results of the present study indicate that combined antioxidant supplements increased performance, egg quality and serum antioxidant levels while lowering MDA in cold-stressed quails.

Animal Feed↗

PubMed1982

The cumulation of chromium and arsenic species in fish (Poecilia reticulata).

Chromium-51 and arsenic-74 were used for the investigation of the uptake and the release of different chromium and arsenic species in fish. It has been found that only trimethylarsine can be rapidly taken up directly from water. The release of chromium(III), consumed by fish in food, is very rapid: about 99.9% of chromium is released within a few days. The same results were obtained with chromium(III) acetylacetonate or chromium(III) ethylenediaminotetraacetate. About 95% of arsenic acid, methylarsonic acid, dimethylarsinic acid or arsenic(III) diethyldithiocarbamate are released within a few days whereas the remaining arsenic is released with the biological half time 35 +/- 5 days.

Animal Feed↗

PubMed1984

Biological monitoring of occupational exposure to different chromium compounds at various valency states.

Chromium concentrations in the air were measured in seven different workroom environments, where exposure to water soluble hexavalent or trivalent compounds was expected. Urinary excretion of chromium was measured before and after the same arbitrarily chosen working day. End-of-shift urinary chromium and its increase above pre-exposure levels were closely related to the concentration of water soluble chromium (VI) in the air. The values corresponding to 50 micrograms m-3 in the air, which is the current threshold limit value in most countries, were 29.8 and 12.2 micrograms g-1 of creatinine, respectively. Urinary chromium in workers exposed to water insoluble chromates or to water soluble chromic (III) sulphate was definitely higher than that observed in subjects not occupationally exposed to chromium compounds, but it cannot be recommended as short-term exposure test for evaluation of the job-related hazard.

Absorption↗

PubMed1993

Using human sweat to extract chromium from chromite ore processing residue: applications to setting health-based cleanup levels.

Chromite ore processing residue (COPR) containing measurable levels of hexavalent and trivalent chromium. [Cr(VI) and Cr(III), respectively] has been used to fill in low-lying areas in Hudson County, N.J. While it has been demonstrated that direct dermal contact with solutions containing Cr(VI) may elicit allergic contact dermatitis (ACD) in previously sensitized individuals, it is unknown to what degree skin moisture may solubilize Cr(VI) from COPR adhering to skin. An accurate estimate of this extraction potential is necessary to establish COPR concentrations of Cr(VI) and Cr(III) that are protective of eliciting ACD in sensitized individuals. The purpose of this study was to measure the extractable fraction of Cr(VI) and total chromium [Cr(III) and Cr(VI)] in soils impacted by COPR using human sweat as the extractant. Human sweat was collected from seven male volunteers. Samples of COPR material containing the following Cr(VI) and total chromium concentrations were collected: Cr(VI), 16, 136, and 1240 ppm; total chromium, 932 and 6660 ppm. The samples were sieved to obtain a uniform particle size < 500 microns. The samples were then mixed with human sweat at 30 degrees C for 12 h, after which the sweat was filtered and analyzed to determine the dissolved concentration of Cr(VI) and total chromium. The data from these analyses show that no detectable levels (limit of detection = 0.010 ppm) of Cr(VI) were leached from COPR containing 16 ppm Cr(VI). At Cr(VI) concentrations of 136 and 1240 ppm, less than 0.1% of the Cr(VI) present in the COPR sample was extracted into sweat, and sweat concentrations were 0.133 ppm Cr(VI) or less. Similarly, the amount of Crtotal extracted was 0.3% or less at COPR concentrations as high as 6600 ppm Crtotal, and sweat concentrations were 2.3 ppm Crtotal or less. If a minimum concentration of 10 ppm (Bagdon and Hazen, 1991) to 54 ppm (Paustenbach et al., 1992) Cr(VI) in sweat is required to elicit an ACD response in chromium-sensitive individuals, the current study results suggest that a COPR Cr(VI) concentration of at least 10,000-54,000 ppm would be required to elicit ACD. If 500 ppm (or greater) of solubilized Cr(III) is required to elicit an ACD response (NJDEPE, 1992a), then a COPR concentration of 250,000 ppm Cr(III) or greater would be required to elicit an allergic response. These results suggest that ACD is unlikely to occur as a result of environmental exposure to the COPR.

Adult↗

PubMed1995

Lead, chromium, and cadmium emission factors during abrasive blasting operations by bridge painters.

Work space airborne concentrations of lead, chromium, and cadmium were measured during abrasive blasting by bridge painters for the determination of emission rates. The operation used compressed air to blast steel grit at steel or metal surfaces, removing lead-based paint. It was enclosed with plastic tarpaulins to prevent the release of lead- and chromium-laden dust. Consequently, workers were at increased risk from exposure by inhalation or ingestion. Area samples were collected in 13 contained work areas on a 4-leaf bridge and adjacent viaduct while blasting was performed. Enclosure volume and exhaust air flow rate were measured for each containment area. Work space airborne concentrations ranged from 196-31,410 micrograms/m3 for lead, 1-657 micrograms/m3 for chromium, and 1-19 micrograms/m3 for cadmium. Mass balance models were used to calculate emission rates and emission factors using the measured area concentrations. Average emission factors on the bridge were 20,400 mg/m2 for lead, 75 mg/m2 for chromium, and 16 mg/m2 for cadmium; and on the viaduct were 8790 mg/m2 for lead, 568 mg/m2 for chromium, and 2.0 mg/m2 for cadmium. These values were validated using estimates of total paint volume and composition on the structure and total waste generation. All estimates were within 50% of each other except chromium estimates for the bridge. The emission factors allow prediction of work space airborne concentrations during similar operations and are a first step in the design and implementation of control measures.

Air Pollutants, Occupational↗

PubMed1999

Chromium and zinc concentrations in pediatric patients receiving long-term parenteral nutrition.

Serum, urine, and parenteral nutrition (PN) chromium and zinc concentrations in pediatric patients receiving long-term PN were studied. Serum, urine, and PN chromium and zinc concentrations were measured at baseline and four to six months later in four infants (less than 1 year old) and seven children (1-12 years old) receiving long-term PN. In the children, serum, urine, and PN solution zinc concentrations were measured monthly after the amino acid product was changed from a standard to a pediatric product with monthly dosages of 0, 20, 30, and 40 mg of cysteine hydrochloride per gram of amino acids. The mean +/- S.D. baseline serum chromium concentration was 4.9+/-1.9 microg/L (normal value, <0.3 microg/L); the urine chromium concentration ranged from 3.4 to 32.2 microg/L. The mean +/- S.D. prescribed chromium dosage was 0.18+/-0.05 microg/kg/day, and the dosage delivered in PN solutions was 0.41+/-0.23 microg/ kg/day. At baseline, the mean +/- S.D. serum zinc concentration was 1383+/-472 microg/L (normal range, 430 to 940 microg/L), and the prescribed and delivered zinc dosages were 177+/-10 and 238+/-145 microg/kg/ day, respectively. With 20, 30, and 40 mg of cysteine per gram of amino acids, the mean +/- S.D. serum zinc concentration was 1728+/-782, 1664+/-349, and 1685+/-268 microg/L, respectively, and the actual zinc dosages delivered were 209+/-10, 270+/-148, and 322+/-194 microg/kg/day, respectively. Serum and urine chromium concentrations were abnormally high in infants and children receiving PN solutions supplemented with normal doses of these trace elements; an escalating dosage of cysteine in the children tended to increase serum and urine zinc concentrations.

Body Height↗